Showing results (161-170 of 456) with videos related to
Sort By:
Pageof 46
Molecular and Cellular Biology|January 1, 1987
Extrachromosomal recombination in mammalian cells as studied with single- and double-stranded DNA substratesF L Lin, K M Sperle, N L SternbergAnnals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tractP H De Mulder, C Theodore, A Sella, et al.European Urology|June 21, 2011
Sequelae of treatment in long-term survivors of testis cancerRobert Abouassaly, Sophie D Fossa, Aleksander Giwercman, et al.European Urology|August 30, 2011
Contemporary role of androgen deprivation therapy for prostate cancerVincenzo Pagliarulo, Sergio Bracarda, Mario A Eisenberger, et al.British Journal of Cancer|November 7, 2014
Comparing comparators: a look at control arms in kidney cancer studies over the yearsS Bracarda, C Porta, M Sisani, et al.European Urology|May 28, 2013
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancerBenjamin A Gartrell, Robert E Coleman, Karim Fizazi, et al.Journal of Molecular Biology|January 5, 1984
Covalent crosslinking of Escherichia coli phenylalanyl-tRNA and valyl-tRNA to the ribosomal A site via photoaffinity probes attached to the 4-thiouridine residueL M Hsu, F L Lin, K Nurse, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumorsC N Sternberg, P H de Mulder, A T van Oosterom, et al.The Journal of Urology|November 22, 2017
Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer StudiesMarco Moschini, Shahrokh F Shariat, Morgan Rouprêt, et al.European Journal of Cancer (Oxford, England : 1990)|March 17, 2018
Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: crossover of a phase 3 studyAna M Molina, Thomas E Hutson, Dmitry Nosov, et al.Pageof 46